Associate Director, Regional Marketing (West Region)

Phoenix, AZ (Remote)

Salary Not AvailableSenior LevelFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Lead regional marketing with cross-functional partners, own the local thought-leader ecosystem, and track regional KPIs to shape how ZYNLONTA is positioned in hematology/oncology markets.

  • Own regional plan development and asset deployment with geo-targeted media and congress activities
  • Coordinate with AOR, field leadership, and TLs to align on regional account plans and advisory boards
  • Build and nurture local KOLs and patient-advocacy events to feed regional programs and insights

Job Description

Lead regional marketing execution across geographies for hematology/oncology, coordinating with the AOR and brand teams while shaping local thought leadership and KOL engagement to drive regional objectives.

  • Lead and execute regional marketing plans
  • Work with the Agency of Record (AOR) and home office to develop and to execute regional marketing plans including asset deployment, media execution (geo-targeting), and congress planning.
  • Identify, monitor, and report key performance metrics for the region
  • Align with cross functional matrix team on local account planning (Associate Director, Strategic Accounts, Hematology Therapeutic Specialists)
  • Identify local and regional HCPs to participate in key commercial projects including webcasts, videos, promotional materials, and training opportunities
  • Identify and develop regional and local thought leaders
  • Identifies, develops, and engages with local and regional KOLs across, Hematology/Oncology and especially within the lymphoma expert community in the region.
  • Works with Agency of Record and brand team to map regional TL influence and support regional account plan development and execution
  • Develop and execute regional advisory boards and third-party program plans
  • Identify and develop local and regional HCPs to participate in the ADC Therapeutics Speaker Bureau for ZYNLONTA and disease state programs
  • Attend key regional and national conferences to meet with TLs and other key customers and gather competitive insights
  • Work with field leadership to coordinate and align on appropriate company presence onsite
  • Arrange meetings with TLs and company leadership
  • Work with Digital marketing on geotargeting and advertising opportunities.
  • Insight gathering for HQ and field leadership
  • Collaborates and communicates with headquarters, the region’s field commercial and medical teams, and Clinical Development to maintain KOL coordination and manage appropriate distinction of roles and boundaries among the expertise areas.
  • Monitors Lymphoma Treater landscape to understand community beliefs about ZYNLONTA and relevant external (competitor) events and data
  • Coordinate and execute local Patient Advocacy events
  • Work with Patient marketing, corporate communications, and sales to effectively support advocacy meetings and events especially where appropriate TL engagement is possible
ADC Therapeutics logo

ADC Therapeutics

4.1 Glassdoor

ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. We are a pioneer in the ADC field with specialized capabilities unique to ADCs from clinical to manufacturing and commercialization with a proven track record that includes an approved and marketed product. Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics is leveraging its expertise to advance IND-enabling activities for a next-generation PSMA-targeting ADC.Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer.For more information, please visit https://www.adctherapeutics.com/.

Founded in 2011
Lausanne, Vaud, CHE
291 employees (6 in marketing)
84% recommend to a friend
69% CEO approval

Traffic Signals

Monthly Visitors
14.4K
Traffic Source Mix
Search
28%
Direct
24.4%
Referral
4.3%
Social
3.7%
Paid
0.6%

Headcount Trend

Current headcount: ~291

Marketing Team

Marketing Team Size
6 (2% of company)

Funding

Total Funding
$1B
Last Raise
$60M
Post IPO Equity, 5 months ago

Funding History

  • Oct 2025
    Post IPO Equity • $60M
  • Jun 2025
    Post IPO Equity • $100M
  • May 2024
    Post IPO Equity • $105M

Recent News